NTRK2 and Alzheimer disease: Deficits in BDNF signaling are discussed to contribute to cognitive dysfunctions in AD [12,13,14], and enhanced signaling through the BDNF receptor tropomyosin related kinase B (TrkB) can ameliorate cognitive symptoms in AD model mice [15,16].